Biggest Ever Private Donation to Cancer Research in Canada
Jan. 21, 2013
/CNW/ - Canadian philanthropists
and the Slaight family made history today with a
gift to The Princess Margaret Cancer Foundation. The extraordinary donation is the biggest ever private gift to cancer research in Canadian history and will advance the Princess Margaret Cancer Centre's Personalized Cancer Medicine initiative.
Ms. Gattuso and Mr. Slaight's gift to The Princess Margaret Cancer Foundation's Billion Dollar Challenge is pledged over ten years, and is an investment in human capital. It will create an unprecedented Personalized Cancer Medicine "superfund to support superstars" that will provide the necessary long-term, sustainable funding to attract, support and retain the best and brightest minds in the world whose sole focus is to eradicate cancer.
were named Philanthropists of the Year by the Association of Fundraising Professionals (AFP). The couple has dedicated their lives to transforming the things that matter to them. Helping cancer patients is at the top of their list. As a 10-year cancer survivor, Ms. Gattuso has seen significant change driven by the dedicated scientists and caregivers at The Princess Margaret over the past decade. For Ms. Gattuso, Mr. Slaight and the Slaight family, The Princess Margaret's vision of Personalized Cancer Medicine resonates and is the reason for their generous gift.
commented, "I have been touched by cancer, as have so many friends and family members. Allan and I are extremely pleased to be able to support The Princess Margaret's Billion Dollar Challenge for Personalized Cancer Medicine and hope others will join us. We believe in The Princess Margaret's vision to conquer cancer in our lifetime."
The Princess Margaret Cancer Centre, one of the top 5 cancer research centres in the world, is revolutionizing cancer care by creating and delivering its own distinct model of Personalized Cancer Medicine encompassing four key themes: detect, diagnose, target and support. Personalized Cancer Medicine will help detect cancers earlier, diagnose cancers more precisely, provide targeted treatment, and better support patients and their families through their cancer journey.